𝘑𝘜𝘚𝘛 𝘖𝘜𝘛: REVIEW of immunobiology of HGSOC. 🔖TILs 🔖Opportunities for immunotherapy 📑go.nature.com/3qJ1pOs By Lana Kandalaft, Denarda Dangaj & George Coukos. #CancerResearch Université de Lausanne CHUV / Centre hospitalier universitaire vaudois Ludwig Cancer.

Just out in Nature News & Views, George Coukos and Denarda Dangaj Laniti consider how data that reveal cellular, molecular and mutational landscape, as ovarian cancer tumours grow and spread, might aid efforts to develop new targeted therapies. Université de Lausanne @chuv Ludwig Cancer

Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma biorxiv.org/cgi/content/sh… #biorxiv_immuno

On behalf of all coauthors, I am happy to share our recent pre-print with the community. lnkd.in/ecu36FuG

Genetics and anatomy sculpt immune-cell partners of ovarian cancer nature.com/articles/d4158… George Coukos

lnkd.in/ecCK5CvC lnkd.in/eTchXfWA

lnkd.in/epsCUYKv lnkd.in/eEYHrwHT

I am delighted to be presenting at the 2023 Ovarian Cancer Australia Symposium for health professionals in Sydney on the 5th of May. I will be presenting on “ Heterogeneity and Immunobiology of High-Grade Serous Ovarian Cancer”.    To register, see the li…lnkd.in/eC8Mh_W7